Øystein Rekdal

Vorstandsvorsitzender bei LYTIX BIOPHARMA

Health Technology

Consumer Services

Aktive Positionen von Øystein Rekdal

Unternehmen	Position	Beginn	Ende
LYTIX BIOPHARMA	Vorstandsvorsitzender	11.09.2019	-
	Gründer	01.01.2003	-
	Direktor/Vorstandsmitglied	26.04.2010	21.04.2011
	Technik-/Wissenschafts-/F&E-Leiter	-	11.09.2019
	Corporate Officer/Principal	01.01.2003	-
University of Tromso	Corporate Officer/Principal	-	-

Unternehmen	Position	Beginn	Ende
Prophylix AS Prophylix AS Pharmaceuticals: MajorHealth Technology Prophylix AS operates as biotech company that offers orphan drug programs and follow-on therapy. The firm develops a prophylactic medicinal product to prevent newborns from Foetal/Neonatal Alloimmune Thrombocytopenia (FNAIT). The company was founded by Bjørn Ragnar Skogen, Jens Kjeldsen-Kragh, Anne Husebekk, and Mette Kjaer in 2008 and is headquartered in Tromso, Norway.	Direktor/Vorstandsmitglied	15.04.2010	-

University of Tromso

Doctorate Degree

International

Norwegen

Operativ

Director/Board Member	2
Corporate Officer/Principal	2
Chief Executive Officer	1

Sektoral

Health Technology	3
Consumer Services	2

Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Börsennotierte Unternehmen	1
LYTIX BIOPHARMA	Health Technology

Private Unternehmen	1
Prophylix AS Prophylix AS Pharmaceuticals: MajorHealth Technology Prophylix AS operates as biotech company that offers orphan drug programs and follow-on therapy. The firm develops a prophylactic medicinal product to prevent newborns from Foetal/Neonatal Alloimmune Thrombocytopenia (FNAIT). The company was founded by Bjørn Ragnar Skogen, Jens Kjeldsen-Kragh, Anne Husebekk, and Mette Kjaer in 2008 and is headquartered in Tromso, Norway.	Health Technology

Private Unternehmen

Health Technology